• R Kopp, R Kuhlen, M Max, and R Rossaint.
• Klinik für Anästhesiologie, Universitätsklinikum der RWTH Aachen, Aachen. ruedger.kopp@post.rwth-aachen.de
• Anaesthesist. 2003 Mar 1;52(3):195-203.

AbstractDifferent therapeutic approaches have recently been developed for treatment of acute respiratory distress syndrome (ARDS) with the aim of improving the outcome. The clinical significance and success of these therapies is variable with respect to evidence based medicine. Lung protective ventilation is accepted as a proven therapy and the use of positive end-expiratory pressure as well as spontaneous breathing during controlled ventilation are common therapies. High frequency ventilation, partial liquid ventilation and pulmonary surfactant application are still in the experimental stage. The prone position is recommended for severe cases of ARDS and the application of inhaled nitric oxide and of extracorporeal membrane oxygenation is established in specialized centers for patients with imminent hypoxia. But for the routine use of these three therapies a clear improvement in outcome could not demonstrated. Recommended drug therapy is limited to the administration of stress doses of corticosteroids and a special anti-inflammatory enteral diet.

13 keywords...

hide…